Gainers & Losers
Mon Apr 13 2026 09:59:59- ICICI Bank share price
- ₹1,349.002.04%
- NTPC share price
- ₹385.851.46%
- Tata Motors Passenger Vehi...
- ₹345.100.74%
- AXIS Bank Ltd share price
- ₹1,353.450.15%
- Bharti Airtel share price
- ₹1,870.300.02%
Active Stocks
Mon Apr 13 2026 10:16:12- Suzlon Energy share price
- ₹45.851.21%
- Yes Bank share price
- ₹18.88-1.10%
- Adani Power share price
- ₹181.403.24%
- Kotak Mahindra Bank share price
- ₹372.15-0.69%
- HDFC Bank share price
- ₹794.05-2.02%
Marksans Pharma Profit & Loss Annual
176.15 -2.50 (-1.40%)Updated : 13 Apr 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Operating Expense | 2,156.73 | 1,789.11 | 1,553.60 | 1,276.74 |
| Diluted Weighted Average Shares | 45.32 | 45.32 | 41.54 | 40.93 |
| Gain( Loss)on Saleof Assets | -0.03 | 0.09 | -0.26 | 0.00 |
| Depreciation/ Amortization | 83.39 | 74.27 | 51.85 | 44.78 |
| Operating Income | 466.11 | 388.30 | 298.54 | 214.10 |
| Net Income | 380.58 | 313.70 | 266.31 | 184.57 |
| Income Availableto Com Excl Extra Ord | 380.58 | 313.70 | 266.31 | 184.57 |
| Other Operating Expenses Total | 16.06 | 63.70 | 126.28 | 29.80 |
| Net Income Before Taxes | 503.97 | 423.53 | 337.65 | 247.51 |
| Minority Interest | -2.04 | -1.19 | 0.99 | -2.25 |
| Net Income After Taxes | 382.62 | 314.90 | 265.32 | 186.81 |
| Income Availableto Com Incl Extra Ord | 380.58 | 313.70 | 266.31 | 184.57 |
| Costof Revenue Total | 1,229.46 | 1,094.24 | 921.36 | 748.02 |
| Gross Profit | 1,393.39 | 1,083.17 | 930.78 | 742.82 |
| Interest Inc( Exp) Net- Non- Op Total | 37.89 | 35.14 | 34.92 | 26.44 |
| Unusual Expense( Income) | -2.28 | - | - | - |
| Diluted Net Income | 380.58 | 313.70 | 266.31 | 184.57 |
| DPS- Common Stock Primary Issue | 0.80 | 0.60 | 0.50 | 0.25 |
| Provisionfor Income Taxes | 121.35 | 108.63 | 72.33 | 60.70 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 380.58 | 313.70 | 266.31 | 184.57 |
| Total Revenue | 2,622.85 | 2,177.41 | 1,852.14 | 1,490.84 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 2,622.85 | 2,177.41 | 1,852.14 | 1,490.84 |
| Selling/ General/ Admin Expenses Total | 830.11 | 556.91 | 454.11 | 454.15 |
| Diluted Normalized EPS | 8.36 | 6.92 | 6.42 | 4.51 |
| Diluted EPS Excluding Extra Ord Items | 8.40 | 6.92 | 6.41 | 4.51 |
| Other Net | - | 0.00 | 4.46 | 6.97 |
*All figures in crores except per share values
Marksans Pharma Quick Links
Marksans Pharma Dividend Marksans Pharma Bonus Marksans Pharma News Marksans Pharma AGM Marksans Pharma Rights Marksans Pharma Splits Marksans Pharma Board Meetings Marksans Pharma Key Metrics Marksans Pharma Shareholdings Marksans Pharma Balance Sheet Marksans Pharma Cashflow Marksans Pharma Q1 Results Marksans Pharma Q2 Results Marksans Pharma Q3 Results Marksans Pharma Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,414.00+23.00(1.65%)
296.20+0.80(0.27%)
801.40-42.95 (-5.09%)
979.80-40.25 (-3.95%)